Meeting of the Presidential Advisory Council on HIV/AIDS, 28562-28563 [2019-12986]

Download as PDF 28562 Federal Register / Vol. 84, No. 118 / Wednesday, June 19, 2019 / Notices form are effective in improving outcomes across the HIV care continuum. Strategies and interventions that meet the review criteria verified by HRSA contractors and approved by HRSA program staff through this data collection will be considered best practices and made available through the online compilation for consideration, adaptation, and replication by other HIV programs. In addition, the best practices will support peer exchange to resolve problems impacting HIV care and treatment and eliminating disparities in health outcomes. Likely Respondents: RWHAP recipients and subrecipients that voluntarily submit a best practice strategy or intervention will participate in the data collection. The project team expects that up to 70 recipients and subrecipients will complete the screening form and 50 will screen eligible and complete the full submission form. For the site visits, the project team will strategically select 30 sites from the universe of submitted eligible initiatives, ensuring a range of scores and representativeness of factors such as Census region, proposed strategy/intervention outcome, priority population, and the type of agency or provider implementing the strategy or intervention. Burden Statement: Burden in this context means the time expended by persons to generate, maintain, retain, disclose, or provide the information requested. This includes the time needed to review instructions; to develop, acquire, install, and utilize technology and systems for the purpose of collecting, validating, and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information; to search data sources; to complete and review the collection of information; and to transmit or otherwise disclose the information. The total annual burden hours estimated for this ICR are summarized in the table below. TOTAL ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Form name Number of responses per respondent Total responses Average burden per response (in hours) Total burden hours Pre-Submission Screening Form ......................................... Submission Form ................................................................. Site Visit Discussion Guide .................................................. Program Manager Interview ......................................... Direct Service Provider Interview ................................. Evaluator Interview ....................................................... 70 50 * 120 30 60 30 1 1 1 1 1 1 70 50 120 30 60 30 0.08 3.00 1.00 1.00 1.00 1.00 5.60 150.00 120.00 30.00 60.00 30.00 Total ....................................................................... ** 240 ........................ 240 ........................ 275.60 * For a total of 120 hours, each of the 30 site visits will include one-hour interviews with a program manager (30 hours), up to two 1-hour interviews with direct service providers (60 hours), and an 1-hour interview with an evaluator (30 hours).’ ** The total number of respondents is 240 as comprised by the number of respondents for the pre-submission screening form (70), the submission form (50), and the site visit discussion guide (120). HRSA specifically requests comments on: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Maria G. Button, Director, Division of the Executive Secretariat. [FR Doc. 2019–12960 Filed 6–18–19; 8:45 am] BILLING CODE 4165–15–P jbell on DSK3GLQ082PROD with NOTICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Presidential Advisory Council on HIV/AIDS Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: VerDate Sep<11>2014 19:06 Jun 18, 2019 Jkt 247001 As stipulated by the Federal Advisory Committee Act, the U.S. Department of Health and Human Service is hereby giving notice that the Presidential Advisory Council on HIV/ AIDS (PACHA or the Council) will be holding the 64th full Council meeting in Jackson, Mississippi. Members will hear a panel presentation regarding Ending the HIV Epidemic: A Plan for America and will discuss possible recommendations regarding programs, policies, and research to promote effective, prevention, treatment and cure of HIV disease and AIDS. The meeting will be open to the public; a public comment session will be held during the meeting. Pre-registration is encouraged for members of the public who wish to attend the meeting and who wish to participate in the public comment session. Individuals who wish to attend the meeting and/or send in their public comment via email should send an email to Caroline Talev, MPA, at Caroline.Talev@hhs.gov. PreRegistration must be complete by Monday, July 1, 2019. SUMMARY: PO 00000 Frm 00104 Fmt 4703 Sfmt 4703 The Council meeting is scheduled to convene on Monday, July 8 from 1:00 p.m. to 5:00 p.m. ET and Tuesday, July 9 from 9:00 to 3:00 p.m. ET (times are tentative and subject to change). The meeting agenda will be posted on the PACHA web page at https://www.hiv.gov/federal-response/ pacha/about-pacha. Public attendance is limited to available space. ADDRESSES: Hilton Jackson located at 1001 E County Line Road, Jackson, Mississippi 39211. The meeting can also be accessed through a live webcast on the day of the meeting. FOR FURTHER INFORMATION CONTACT: Ms. Caroline Talev, MPA, Public Health Analyst, Presidential Advisory Council on HIV/AIDS, 330 C Street SW, Room L106B, Washington, DC 20024; (202) 795–7622 or Caroline.Talev@hhs.gov. Additional information can be obtained by accessing the Council’s page on the HIV.gov site at www.hiv.gov/pacha. SUPPLEMENTARY INFORMATION: PACHA was established by Executive Order 12963, dated June 14, 1995, as amended by Executive Order 13009, dated June 14, 1996 and is currently operating DATES: E:\FR\FM\19JNN1.SGM 19JNN1 Federal Register / Vol. 84, No. 118 / Wednesday, June 19, 2019 / Notices jbell on DSK3GLQ082PROD with NOTICES under the authority given in Executive Order 13811, dated September 29, 2017. The Council was established to provide advice, information, and recommendations to the Secretary regarding programs and policies intended to promote effective prevention and care of HIV infection and AIDS. The functions of the Council are solely advisory in nature. The Council consists of not more than 25 members. Council members are selected from prominent community leaders with particular expertise in, or knowledge of, matters concerning HIV and AIDS, public health, global health, philanthropy, marketing or business, as well as other national leaders held in high esteem from other sectors of society. Council members are appointed by the Secretary or designee, in consultation with the White House. The agenda for will be posted on HIV.gov at https://www.hiv.gov/federal-response/ pacha/about-pacha. Public attendance at the meeting is limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify Caroline Talev at Caroline.Talev@hhs.gov. Due to space constraints, pre-registration for public attendance is advisable and can be accomplished by contacting Caroline Talev at Caroline.Talev@hhs.gov by close of business Monday, July 1, 2019. Members of the public will have the opportunity to provide comments during the meeting. Comments will be limited to two minutes per speaker. Any individual who wishes to participate in the public comment session must register with Caroline Talev at Caroline.Talev@hhs.gov by close of business Monday, July 1, 2019; registration for public comment will not be accepted by telephone. Individuals are encouraged to provide a written statement of any public comment(s) for accurate minute taking purposes. Public comment will be limited to two minutes per speaker. Any members of the public who wish to have printed material distributed to PACHA members at the meeting are asked to submit, at a minimum, 1 copy of the material(s) to Caroline Talev, no later than close of business on Monday, July 1, 2019. Dated: May 31, 2019. B. Kaye Hayes, Executive Director, Presidential Advisory Council on HIV/AIDS, Deputy Director, Office of HIV/AIDS and Infectious Disease Policy, Office of the Assistant Secretary for Health, Department of Health and Human Services. [FR Doc. 2019–12986 Filed 6–18–19; 8:45 am] BILLING CODE 4150–43–P VerDate Sep<11>2014 19:06 Jun 18, 2019 Jkt 247001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: AIDS and Related Research. Date: July 8, 2019. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Shalanda A. Bynum, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3206, Bethesda, MD 20892, 301–755–4355, bynumsa@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR–19– 209: Next Generation Multipurpose Prevention Technologies. Date: July 10, 2019. Time: 12:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, RKL II, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Barna Dey, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3184, Bethesda, MD 20892, 301–451–2796, bdey@ mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Digestive Sciences. Date: July 11, 2019. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Ganesan Ramesh, Ph.D., Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2182 MSC 7818, Bethesda, MD 20892, 301–827–5467, ganesan.ramesh@nih.gov. PO 00000 Frm 00105 Fmt 4703 Sfmt 4703 28563 Name of Committee: AIDS and Related Research Integrated Review Group; HIV/ AIDS Intra- and Inter-personal Determinants and Behavioral Interventions Study Section. Date: July 11–12, 2019. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Sheraton Grand Seattle, 1400 6th Avenue, Seattle, WA 98101. Contact Person: Mark P. Rubert, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD 20892, 301–806– 6596, rubertm@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: GI Mucosal Immunology and Pathology. Date: July 11, 2019. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Meenakshisundar Ananthanarayanan, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2178, Bethesda, MD 20892, 301– 827–6281, meena.ananthanarayanan@ nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Health Services Research on Minority Health and Health Disparities. Date: July 12, 2019. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: The Dupont Hotel, 1500 New Hampshire Avenue NW, Washington, DC 20036. Contact Person: Mark Allen Vosvick, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3110, Bethesda, MD 20892, mark.vosvick@nih.gov. Name of Committee: AIDS and Related Research Integrated Review Group; HIV Molecular Virology, Cell Biology, and Drug Development Study Section. Date: July 15–16, 2019. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Kenneth A. Roebuck, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5214, MSC 7852, Bethesda, MD 20892, (301) 435– 1166, roebuckk@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Community Health and Health Disparities. Date: July 15, 2019. Time: 12:00 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\19JNN1.SGM 19JNN1

Agencies

[Federal Register Volume 84, Number 118 (Wednesday, June 19, 2019)]
[Notices]
[Pages 28562-28563]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-12986]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Presidential Advisory Council on HIV/AIDS

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S. 
Department of Health and Human Service is hereby giving notice that the 
Presidential Advisory Council on HIV/AIDS (PACHA or the Council) will 
be holding the 64th full Council meeting in Jackson, Mississippi. 
Members will hear a panel presentation regarding Ending the HIV 
Epidemic: A Plan for America and will discuss possible recommendations 
regarding programs, policies, and research to promote effective, 
prevention, treatment and cure of HIV disease and AIDS. The meeting 
will be open to the public; a public comment session will be held 
during the meeting. Pre-registration is encouraged for members of the 
public who wish to attend the meeting and who wish to participate in 
the public comment session. Individuals who wish to attend the meeting 
and/or send in their public comment via email should send an email to 
Caroline Talev, MPA, at [email protected]. Pre-Registration must 
be complete by Monday, July 1, 2019.

DATES: The Council meeting is scheduled to convene on Monday, July 8 
from 1:00 p.m. to 5:00 p.m. ET and Tuesday, July 9 from 9:00 to 3:00 
p.m. ET (times are tentative and subject to change). The meeting agenda 
will be posted on the PACHA web page at https://www.hiv.gov/federal-response/pacha/about-pacha. Public attendance is limited to available 
space.

ADDRESSES: Hilton Jackson located at 1001 E County Line Road, Jackson, 
Mississippi 39211. The meeting can also be accessed through a live 
webcast on the day of the meeting.

FOR FURTHER INFORMATION CONTACT: Ms. Caroline Talev, MPA, Public Health 
Analyst, Presidential Advisory Council on HIV/AIDS, 330 C Street SW, 
Room L106B, Washington, DC 20024; (202) 795-7622 or 
[email protected]. Additional information can be obtained by 
accessing the Council's page on the HIV.gov site at www.hiv.gov/pacha.

SUPPLEMENTARY INFORMATION: PACHA was established by Executive Order 
12963, dated June 14, 1995, as amended by Executive Order 13009, dated 
June 14, 1996 and is currently operating

[[Page 28563]]

under the authority given in Executive Order 13811, dated September 29, 
2017. The Council was established to provide advice, information, and 
recommendations to the Secretary regarding programs and policies 
intended to promote effective prevention and care of HIV infection and 
AIDS. The functions of the Council are solely advisory in nature.
    The Council consists of not more than 25 members. Council members 
are selected from prominent community leaders with particular expertise 
in, or knowledge of, matters concerning HIV and AIDS, public health, 
global health, philanthropy, marketing or business, as well as other 
national leaders held in high esteem from other sectors of society. 
Council members are appointed by the Secretary or designee, in 
consultation with the White House. The agenda for will be posted on 
HIV.gov at https://www.hiv.gov/federal-response/pacha/about-pacha.
    Public attendance at the meeting is limited to space available. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify Caroline Talev at [email protected]. Due to space 
constraints, pre-registration for public attendance is advisable and 
can be accomplished by contacting Caroline Talev at 
[email protected] by close of business Monday, July 1, 2019. 
Members of the public will have the opportunity to provide comments 
during the meeting. Comments will be limited to two minutes per 
speaker. Any individual who wishes to participate in the public comment 
session must register with Caroline Talev at [email protected] by 
close of business Monday, July 1, 2019; registration for public comment 
will not be accepted by telephone. Individuals are encouraged to 
provide a written statement of any public comment(s) for accurate 
minute taking purposes. Public comment will be limited to two minutes 
per speaker. Any members of the public who wish to have printed 
material distributed to PACHA members at the meeting are asked to 
submit, at a minimum, 1 copy of the material(s) to Caroline Talev, no 
later than close of business on Monday, July 1, 2019.

    Dated: May 31, 2019.
B. Kaye Hayes,
Executive Director, Presidential Advisory Council on HIV/AIDS, Deputy 
Director, Office of HIV/AIDS and Infectious Disease Policy, Office of 
the Assistant Secretary for Health, Department of Health and Human 
Services.
[FR Doc. 2019-12986 Filed 6-18-19; 8:45 am]
BILLING CODE 4150-43-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.